Vistal, Charles G.

HRN: 05-45-43  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/01/2026
08/07/2026
IV
4.5
Q6h
Urosepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: